| Year |
Citation |
Score |
| 2024 |
Zhao R, Sanstead E, Alarid-Escudero F, Huchko M, Silverberg M, Smith-Mccune K, Gregorich SE, Leyden W, Kuppermann M, Sawaya GF, Kulasingam S. Primary HPV screening compared with other cervical cancer screening strategies in women with HIV: a cost-effectiveness study. Aids (London, England). PMID 39229757 DOI: 10.1097/QAD.0000000000004002 |
0.413 |
|
| 2024 |
Alarid-Escudero F, Gracia V, Wolf M, Zhao R, Easterly CW, Kim JJ, Canfell K, de Kok IMCM, Barnabas RV, Kulasingam S. State-level disparities in cervical cancer prevention and impact on outcomes in the U.S.: A modeling study. Medrxiv : the Preprint Server For Health Sciences. PMID 38947042 DOI: 10.1101/2024.06.11.24308795 |
0.358 |
|
| 2023 |
Xiong S, Ghebre R, Kulasingam S, Mason SM, Pratt RJ, Lazovich D. Exploring factors associated with preferences for human papillomavirus (HPV) self-sampling among racially- and ethnically-diverse women in Minnesota: A cross-sectional study. Preventive Medicine Reports. 34: 102243. PMID 37234567 DOI: 10.1016/j.pmedr.2023.102243 |
0.346 |
|
| 2023 |
Zhao R, Sekar P, Bennis SL, Kulasingam S. A systematic review of the association between smoking exposure and HPV-related cervical cell abnormality among women living with HIV: Implications for prevention strategies. Preventive Medicine. 170: 107494. PMID 37001607 DOI: 10.1016/j.ypmed.2023.107494 |
0.334 |
|
| 2022 |
Xiong S, Lazovich A, Hassan F, Ambo N, Ghebre R, Kulasingam S, Mason SM, Pratt RJ. Health care personnel's perspectives on human papillomavirus (HPV) self-sampling for cervical cancer screening: a pre-implementation, qualitative study. Implementation Science Communications. 3: 130. PMID 36514133 DOI: 10.1186/s43058-022-00382-3 |
0.407 |
|
| 2022 |
Teoh D, Nam G, Aase DA, Russell R, Melton GB, Kulasingam S, Vogel RI. Test Performance of Cervical Cytology Among Adults With vs Without Human Papillomavirus Vaccination. Jama Network Open. 5: e2214020. PMID 35612854 DOI: 10.1001/jamanetworkopen.2022.14020 |
0.427 |
|
| 2022 |
Zhao R, Liang S, Teoh D, Fei Y, Pang X, Kulasingam S. A comprehensive cross-sectional survey to identify barriers and facilitators of cervical cancer screening in women with HIV in Guangxi, China. Infectious Agents and Cancer. 17: 12. PMID 35331300 DOI: 10.1186/s13027-022-00426-2 |
0.33 |
|
| 2021 |
Yared N, Malone M, Welo E, Mohammed I, Groene E, Flory M, Basta NE, Horvath KJ, Kulasingam S. Challenges related to human papillomavirus (HPV) vaccine uptake in Minnesota: clinician and stakeholder perspectives. Cancer Causes & Control : Ccc. PMID 34247291 DOI: 10.1007/s10552-021-01459-5 |
0.336 |
|
| 2020 |
Holt HK, Kulasingam S, Sanstead EC, Alarid-Escudero F, Smith-McCune K, Gregorich SE, Silverberg MJ, Huchko MJ, Kuppermann M, Sawaya GF. Discussing Cervical Cancer Screening Options: Outcomes to Guide Conversations Between Patients and Providers. Mdm Policy & Practice. 5: 2381468320952409. PMID 32885045 DOI: 10.1177/2381468320952409 |
0.428 |
|
| 2020 |
Simms KT, Yuill S, Killen J, Smith MA, Kulasingam S, de Kok IMCM, van Ballegooijen M, Burger EA, Regan C, Kim JJ, Canfell K. Historical and projected hysterectomy rates in the USA: Implications for future observed cervical cancer rates and evaluating prevention interventions. Gynecologic Oncology. PMID 32723676 DOI: 10.1016/J.Ygyno.2020.05.030 |
0.386 |
|
| 2020 |
de Kok IMCM, Burger EA, Naber SK, Canfell K, Killen J, Simms K, Kulasingam S, Groene E, Sy S, Kim JJ, van Ballegooijen M. The Impact of Different Screening Model Structures on Cervical Cancer Incidence and Mortality Predictions: The Maximum Clinical Incidence Reduction (MCLIR) Methodology. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 272989X20924007. PMID 32486894 DOI: 10.1177/0272989X20924007 |
0.427 |
|
| 2020 |
Silverberg MJ, Leyden WA, Lam JO, Chao CR, Gregorich SE, Huchko MJ, Kulasingam S, Kuppermann M, Smith-McCune KK, Sawaya GF. Effectiveness of 'catch-up' human papillomavirus vaccination to prevent cervical neoplasia in immunosuppressed and non-immunosuppressed women. Vaccine. PMID 32446836 DOI: 10.1016/J.Vaccine.2020.05.004 |
0.466 |
|
| 2020 |
Malagón T, Mayrand MH, Ogilvie G, Gotlieb WH, Blake J, Bouchard C, Franco EL, Kulasingam S. Modeling the balance of benefits and harms of cervical cancer screening with cytology and human papillomavirus testing. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32332032 DOI: 10.1158/1055-9965.Epi-20-0190 |
0.49 |
|
| 2019 |
Burger EA, de Kok IMCM, Groene E, Killen J, Canfell K, Kulasingam S, Kuntz KM, Matthijsse S, Regan C, Simms K, Smith M, Sy S, Alarid-Escudero F, Vaidyanathan V, van Ballegooijen M, et al. Estimating the Natural History of Cervical Carcinogenesis Using Simulation Models: A CISNET Comparative Analysis. Journal of the National Cancer Institute. PMID 31821501 DOI: 10.1093/Jnci/Djz227 |
0.487 |
|
| 2019 |
Teoh D, Vogel RI, Langer A, Bharucha J, Geller MA, Harwood E, Kulasingam S, Melton GB. Effect of an Electronic Health Record Decision Support Alert to Decrease Excess Cervical Cancer Screening. Journal of Lower Genital Tract Disease. 23: 253-258. PMID 31592972 DOI: 10.1097/Lgt.0000000000000484 |
0.455 |
|
| 2019 |
Groene EA, Mohammed I, Horvath K, Basta NE, Yared N, Kulasingam S. Online media scans: Applying systematic review techniques to assess statewide human papillomavirus vaccination activities. Journal of Public Health Research. 8: 1623. PMID 31572697 DOI: 10.4081/Jphr.2019.1623 |
0.417 |
|
| 2019 |
Canfell K, Kim JJ, Kulasingam S, Berkhof J, Barnabas R, Bogaards JA, Campos N, Jennett C, Sharma M, Simms KT, Smith MA, Velentzis LS, Brisson M, Jit M. HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control. Papillomavirus Research (Amsterdam, Netherlands). 100184. PMID 31505258 DOI: 10.1016/J.Pvr.2019.100184 |
0.486 |
|
| 2019 |
Feder MA, Kulasingam SL, Kiviat NB, Mao C, Nelson EJ, Winer RL, Whitham HK, Lin J, Hawes SE. Correlates of Human Papillomavirus Vaccination and Association with HPV-16 and HPV-18 DNA Detection in Young Women. Journal of Women's Health (2002). PMID 31264912 DOI: 10.1089/Jwh.2018.7340 |
0.473 |
|
| 2019 |
Sawaya GF, Sanstead E, Alarid-Escudero F, Smith-McCune K, Gregorich SE, Silverberg MJ, Leyden W, Huchko MJ, Kuppermann M, Kulasingam S. Estimated Quality of Life and Economic Outcomes Associated With 12 Cervical Cancer Screening Strategies: A Cost-effectiveness Analysis. Jama Internal Medicine. 179: 867-878. PMID 31081851 DOI: 10.1001/Jamainternmed.2019.0299 |
0.45 |
|
| 2019 |
Yared NF, Horvath KJ, Baker JV, Thyagarajan B, Waterboer T, Kulasingam S. Concordance of Self- and Clinician-Collected Anal Swabs to Detect Human Papillomavirus in a Sample of HIV-Negative Men. Journal of Lower Genital Tract Disease. PMID 30946259 DOI: 10.1097/Lgt.0000000000000475 |
0.35 |
|
| 2019 |
Grimm-Geris JM, Dunmire S, Duval LM, Filtz EA, Leuschen HJ, Schmeling DO, Kulasingam SL, Balfour HH. Screening for Epstein-Barr virus (EBV) infection status in university freshmen: acceptability of a gingival swab method. Epidemiology and Infection. 147. PMID 30869049 DOI: 10.1017/S0950268819000335 |
0.307 |
|
| 2019 |
Malagón T, Kulasingam S, Franco EL. Limitations of simulation models for cervical cancer screening - Authors' reply. The Lancet. Oncology. 20: e69. PMID 30712802 DOI: 10.1016/S1470-2045(19)30012-9 |
0.433 |
|
| 2018 |
Malagón T, Kulasingam S, Mayrand MH, Ogilvie G, Smith L, Bouchard C, Gotlieb W, Franco EL. Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study. The Lancet. Oncology. PMID 30392810 DOI: 10.1016/S1470-2045(18)30536-9 |
0.509 |
|
| 2018 |
Silverberg MJ, Leyden WA, Lam JO, Gregorich SE, Huchko MJ, Kulasingam S, Kuppermann M, Smith-McCune KK, Sawaya GF. Effectiveness of catch-up human papillomavirus vaccination on incident cervical neoplasia in a US health-care setting: a population-based case-control study. The Lancet. Child & Adolescent Health. 2: 707-714. PMID 30236379 DOI: 10.1016/S2352-4642(18)30220-7 |
0.485 |
|
| 2018 |
Kline SE, Sanstead EC, Johnson JR, Kulasingam SL. Cost-effectiveness of pre-operative Staphylococcus aureus screening and decolonization. Infection Control and Hospital Epidemiology. 1-7. PMID 30231943 DOI: 10.1017/Ice.2018.228 |
0.305 |
|
| 2018 |
Easterly C, Alarid-Escudero F, Enns E, Kulasingam SL. Revisiting assumptions about age-based mixing representations in mathematical models of sexually transmitted infections. Vaccine. 36: 5572-5579. PMID 30093290 DOI: 10.1016/J.Vaccine.2018.07.058 |
0.395 |
|
| 2018 |
Teoh D, Hultman G, DeKam M, Isaksson Vogel R, Downs LS, Geller MA, Le C, Melton G, Kulasingam S. Excess Cost of Cervical Cancer Screening Beyond Recommended Screening Ages or After Hysterectomy in a Single Institution. Journal of Lower Genital Tract Disease. PMID 29733302 DOI: 10.1097/Lgt.0000000000000400 |
0.472 |
|
| 2018 |
Sanstead E, Basta NE, Martin K, Cruz V, Ehresmann K, Kulasingam SL. Pertussis and the Minnesota State Fair: Demonstrating a Novel Setting for Efficiently Conducting Seroepidemiologic Studies. Journal of Community Health. 43: 937-943. PMID 29627911 DOI: 10.1007/S10900-018-0508-Y |
0.325 |
|
| 2018 |
Teoh D, Shaikh R, Vogel RI, Zoellner T, Carson L, Kulasingam S, Lou E. A Cross-Sectional Review of Cervical Cancer Messages on Twitter During Cervical Cancer Awareness Month. Journal of Lower Genital Tract Disease. 22: 8-12. PMID 29271850 DOI: 10.1097/Lgt.0000000000000363 |
0.475 |
|
| 2018 |
Silverberg MJ, Leyden WA, Chi A, Gregorich S, Huchko MJ, Kulasingam S, Kuppermann M, Seto A, Smith-McCune KK, Sawaya GF. Human Immunodeficiency Virus (HIV)- and Non-HIV-Associated Immunosuppression and Risk of Cervical Neoplasia. Obstetrics and Gynecology. 131: 47-55. PMID 29215531 DOI: 10.1097/Aog.0000000000002371 |
0.304 |
|
| 2017 |
Yared N, Horvath K, Fashanu O, Zhao R, Baker J, Kulasingam S. OPTIMIZING SCREENING FOR SEXUALLY TRANSMITTED INFECTIONS IN MEN USING SELF-COLLECTED SWABS - A SYSTEMATIC REVIEW. Sexually Transmitted Diseases. PMID 29465701 DOI: 10.1097/Olq.0000000000000739 |
0.321 |
|
| 2017 |
Whitham HK, Hawes SE, Chu H, Oakes JM, Lifson AR, Kiviat NB, Sow PS, Gottlieb GS, Ba S, Sy MP, Kulasingam SL. A Comparison of the Natural History of HPV Infection and Cervical Abnormalities among HIV-Positive and HIV-Negative Women in Senegal, Africa. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 28515108 DOI: 10.1158/1055-9965.Epi-16-0700 |
0.423 |
|
| 2017 |
Mao C, Kulasingam SL, Whitham HK, Hawes SE, Lin J, Kiviat NB. Clinician and Patient Acceptability of Self-Collected Human Papillomavirus Testing for Cervical Cancer Screening. Journal of Women's Health (2002). PMID 28332888 DOI: 10.1089/Jwh.2016.5965 |
0.498 |
|
| 2017 |
Teoh D, Isaksson Vogel R, Hultman G, Monu M, Downs L, Geller MA, Le C, Melton-Meaux G, Kulasingam S. Single Health System Adherence to 2012 Cervical Cancer Screening Guidelines at Extremes of Age and Posthysterectomy. Obstetrics and Gynecology. PMID 28178049 DOI: 10.1097/Aog.0000000000001895 |
0.413 |
|
| 2017 |
Yared N, Horvath K, Fashanu O, Zhao R, Baker J, Kulasingam S. Optimizing Screening for Sexually Transmitted Infections in Men Using Self-Collected Swabs — A Systematic Review Open Forum Infectious Diseases. 4. DOI: 10.1093/Ofid/Ofx163.094 |
0.37 |
|
| 2015 |
Nelson EJ, Hughes J, Oakes JM, Pankow JS, Kulasingam SL. Geospatial patterns of human papillomavirus vaccine uptake in Minnesota. Bmj Open. 5: e008617. PMID 26316652 DOI: 10.1136/Bmjopen-2015-008617 |
0.38 |
|
| 2015 |
Sanstead E, Kenyon C, Rowley S, Enns E, Miller C, Ehresmann K, Kulasingam S. Understanding Trends in Pertussis Incidence: An Agent-Based Model Approach. American Journal of Public Health. 105: e42-7. PMID 26180973 DOI: 10.2105/Ajph.2015.302794 |
0.306 |
|
| 2015 |
Whitham HK, Kulasingam SL. The significantly lower risk of cervical cancer at and after the recommended age to begin and end screening compared to breast and colorectal cancer Preventive Medicine. 76: 135-140. PMID 25937628 DOI: 10.1016/J.Ypmed.2015.01.035 |
0.443 |
|
| 2015 |
Sawaya GF, Kulasingam S, Denberg TD, Qaseem A. Cervical Cancer Screening in Average-Risk Women: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians. Annals of Internal Medicine. 162: 851-9. PMID 25928075 DOI: 10.7326/M14-2426 |
0.429 |
|
| 2015 |
Nelson EJ, Hughes J, Oakes JM, Thyagarajan B, Pankow JS, Kulasingam SL. Human Papillomavirus Infection in Women Who Submit Self-collected Vaginal Swabs After Internet Recruitment. Journal of Community Health. 40: 379-86. PMID 25257565 DOI: 10.1007/S10900-014-9948-1 |
0.448 |
|
| 2015 |
Teoh DGK, Marriott AE, Isaksson Vogel R, Marriott RT, Lais CW, Downs LS, Kulasingam SL. Adherence to the 2012 national cervical cancer screening guidelines: A pilot study American Journal of Obstetrics and Gynecology. 212: 62e1-62e9. PMID 24992692 DOI: 10.1016/J.Ajog.2014.06.057 |
0.445 |
|
| 2014 |
Nelson EJ, Hughes J, Oakes JM, Pankow JS, Kulasingam SL. Estimation of geographic variation in human papillomavirus vaccine uptake in men and women: an online survey using facebook recruitment. Journal of Medical Internet Research. 16: e198. PMID 25231937 DOI: 10.2196/Jmir.3506 |
0.43 |
|
| 2014 |
Nelson EJ, Hughes J, Kulasingam SL. Spatial patterns of human papillomavirus-associated cancers within the state of Minnesota, 1998-2007. Spatial and Spatio-Temporal Epidemiology. 9: 13-21. PMID 24889990 DOI: 10.1016/J.Sste.2014.02.003 |
0.501 |
|
| 2013 |
Kulasingam SL, Havrilesky LJ, Ghebre R, Myers ER. Screening for cervical cancer: A modeling study for the us preventive services task force Journal of Lower Genital Tract Disease. 17: 193-202. PMID 23519288 DOI: 10.1097/Lgt.0B013E3182616241 |
0.487 |
|
| 2012 |
Canfell K, Chesson H, Kulasingam SL, Berkhof J, Diaz M, Kim JJ. Modeling preventative strategies against human papillomavirus-related disease in developed countries Vaccine. 30. PMID 23199959 DOI: 10.1016/J.Vaccine.2012.06.091 |
0.463 |
|
| 2012 |
Adegoke O, Kulasingam SL, Virnig BA. Cervical cancer trends in the United States: a 35-year population-based analysis. Journal of Womens Health. 21: 1031-1037. PMID 22816437 DOI: 10.1089/Jwh.2011.3385 |
0.417 |
|
| 2012 |
Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, Wentzensen N, Downs LS, Spitzer M, Moscicki AB, Franco EL, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. American Journal of Clinical Pathology. 137: 516-42. PMID 22431528 DOI: 10.1309/Ajcptgd94Evrsjcg |
0.516 |
|
| 2012 |
Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, Wentzensen N, Downs LS, Spitzer M, Moscicki AB, Franco EL, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Ca: a Cancer Journal For Clinicians. 62: 147-72. PMID 22422631 DOI: 10.3322/Caac.21139 |
0.516 |
|
| 2012 |
Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain JM, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, Wentzensen N, Downs LS, Spitzer M, Moscicki AB, Franco EL, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Journal of Lower Genital Tract Disease. 16: 175-204. PMID 22418039 DOI: 10.1097/Lgt.0B013E31824Ca9D5 |
0.509 |
|
| 2012 |
Kulasingam SL, Havrilesky L. Health economics of screening for gynaecological cancers Best Practice & Research in Clinical Obstetrics & Gynaecology. 26: 163-173. PMID 22138003 DOI: 10.1016/J.Bpobgyn.2011.10.013 |
0.501 |
|
| 2012 |
V Barnabas R, Kulasingam SL. Economic evaluations of human papillomavirus vaccines. Expert Review of Pharmacoeconomics & Outcomes Research. 7: 251-67. PMID 20528312 DOI: 10.1586/14737167.7.3.251 |
0.417 |
|
| 2012 |
V Barnabas R, Kulasingam SL. Economic evaluations of human papillomavirus vaccines. Expert Review of Pharmacoeconomics & Outcomes Research. 7: 251-67. PMID 20528312 DOI: 10.1586/14737167.7.3.251 |
0.417 |
|
| 2011 |
Havrilesky LJ, Sanders GD, Kulasingam S, Chino JP, Berchuck A, Marks JR, Myers ER. Development of an ovarian cancer screening decision model that incorporates disease heterogeneity: implications for potential mortality reduction. Cancer. 117: 545-53. PMID 21254049 DOI: 10.1002/Cncr.25624 |
0.366 |
|
| 2010 |
Melnikow J, Kulasingam S, Slee C, Helms LJ, Kuppermann M, Birch S, McGahan CE, Coldman A, Chan BK, Sawaya GF. Surveillance after treatment for cervical intraepithelial neoplasia: outcomes, costs, and cost-effectiveness. Obstetrics and Gynecology. 116: 1158-70. PMID 20966702 DOI: 10.1097/Aog.0B013E3181F88E72 |
0.368 |
|
| 2010 |
Balasubramanian A, Kulasingam SL, Baer A, Hughes JP, Myers ER, Mao C, Kiviat NB, Koutsky LA. Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples. Journal of Lower Genital Tract Disease. 14: 185-95. PMID 20592553 DOI: 10.1097/Lgt.0B013E3181Cd6D36 |
0.515 |
|
| 2010 |
Kuppermann M, Melnikow J, Slee C, Tancredi DJ, Kulasingam S, Birch S, Helms LJ, Bayoumi AM, Sawaya GF. Preferences for surveillance strategies for women treated for high-grade precancerous cervical lesions Gynecologic Oncology. 118: 108-115. PMID 20553960 DOI: 10.1016/J.Ygyno.2010.05.002 |
0.483 |
|
| 2010 |
Saraiya M, Martinez G, Glaser K, Kulasingam SL. Pap testing and sexual activity among young women in the United States Obstetrical & Gynecological Survey. 65: 167-169. DOI: 10.1097/01.Ogx.0000369675.11463.5A |
0.355 |
|
| 2009 |
Saraiya M, Martinez G, Glaser K, Kulasingam SL. Pap testing and sexual activity among young women in the United States. Obstetrics & Gynecology. 114: 1213-1219. PMID 19935021 DOI: 10.1097/Aog.0B013E3181Be3Db4 |
0.353 |
|
| 2009 |
Kulasingam SL, Rajan R, St Pierre Y, Atwood CV, Myers ER, Franco EL. Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis. Bmc Medicine. 7: 69. PMID 19900264 DOI: 10.1186/1741-7015-7-69 |
0.521 |
|
| 2009 |
Harris TG, Miller L, Kulasingam SL, Feng Q, Kiviat NB, Schwartz SM, Koutsky LA. Depot-medroxyprogesterone acetate and combined oral contraceptive use and cervical neoplasia among women with oncogenic human papillomavirus infection. American Journal of Obstetrics and Gynecology. 200: 489.e1-8. PMID 19375566 DOI: 10.1016/J.Ajog.2009.01.030 |
0.456 |
|
| 2009 |
Havrilesky LJ, Broadwater G, Davis DM, Nolte KC, Barnett JC, Myers ER, Kulasingam S. Determination of quality of life-related utilities for health states relevant to ovarian cancer diagnosis and treatment. Gynecologic Oncology. 113: 216-20. PMID 19217148 DOI: 10.1016/J.Ygyno.2008.12.026 |
0.323 |
|
| 2008 |
Havrilesky LJ, Secord AA, Darcy KM, Armstrong DK, Kulasingam S. Cost Effectiveness of Intraperitoneal Compared With Intravenous Chemotherapy for Women With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study Journal of Clinical Oncology. 26: 4144-4150. PMID 18757328 DOI: 10.1200/Jco.2007.13.1961 |
0.32 |
|
| 2008 |
Havrilesky LJ, Sanders GD, Kulasingam S, Myers ER. Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it? Gynecologic Oncology. 111: 179-87. PMID 18722004 DOI: 10.1016/J.Ygyno.2008.07.006 |
0.44 |
|
| 2008 |
Baseman JG, Kulasingam SL, Harris TG, Hughes JP, Kiviat NB, Mao C, Koutsky LA. Evaluation of primary cervical cancer screening with an oncogenic human papillomavirus DNA test and cervical cytologic findings among women who attended family planning clinics in the United States. American Journal of Obstetrics and Gynecology. 199: 26.e1-8. PMID 18313636 DOI: 10.1016/J.Ajog.2007.11.051 |
0.491 |
|
| 2008 |
Kulasingam SL, Benard S, Barnabas RV, Largeron N, Myers ER. Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis. Cost Effectiveness and Resource Allocation : C/E. 6: 4. PMID 18279515 DOI: 10.1186/1478-7547-6-4 |
0.411 |
|
| 2008 |
Kulasingam SL, Benard S, Barnabas RV, Largeron N, Myers ER. Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis. Cost Effectiveness and Resource Allocation : C/E. 6: 4. PMID 18279515 DOI: 10.1186/1478-7547-6-4 |
0.411 |
|
| 2007 |
Kulasingam SL, Pagliusi S, Myers E. Potential effects of decreased cervical cancer screening participation after HPV vaccination: An example from the U.S Vaccine. 25: 8110-8113. PMID 17961877 DOI: 10.1016/J.Vaccine.2007.09.035 |
0.521 |
|
| 2007 |
Kulasingam SL, Connelly L, Conway E, Hocking JS, Myers E, Regan DG, Roder D, Ross J, Wain G. A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program. Sexual Health. 4: 165-175. PMID 17931529 DOI: 10.1071/Sh07043 |
0.478 |
|
| 2007 |
Jewell EL, Kulasingam S, Myers ER, Secord AA, Havrilesky LJ. Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: A cost effectiveness analysis Gynecologic Oncology. 107: 532-540. PMID 17900674 DOI: 10.1016/J.Ygyno.2007.08.056 |
0.352 |
|
| 2007 |
Havrilesky LJ, Secord AA, Kulasingam SL, Myers E. Management of platinum-sensitive recurrent ovarian cancer: A cost-effectiveness analysis Gynecologic Oncology. 107: 211-218. PMID 17870150 DOI: 10.1016/J.Ygyno.2007.06.029 |
0.306 |
|
| 2007 |
Kulasingam SL. Implementation of an HPV-vaccination program: Key factors for success Disease Management and Health Outcomes. 15: 141-149. DOI: 10.2165/00115677-200715030-00003 |
0.508 |
|
| 2006 |
Bidus MA, Maxwell GL, Kulasingam S, Rose GS, Elkas JC, Chernofsky M, Myers ER. Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening Obstetrics and Gynecology. 107: 997-1005. PMID 16648402 DOI: 10.1097/01.Aog.0000210529.70226.0A |
0.537 |
|
| 2006 |
Cuzick J, Clavel C, Petry KU, Meijer CJLM, Hoyer H, Ratnam S, Szarewski A, Birembaut P, Kulasingam SL, Sasieni P, Iftner T. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. International Journal of Cancer. 119: 1095-1101. PMID 16586444 DOI: 10.1002/Ijc.21955 |
0.498 |
|
| 2006 |
Kulasingam SL, Myers ER, Lawson HW, McConnell KJ, Kerlikowske K, Melnikow J, Washington AE, Sawaya GF. Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests. Obstetrics and Gynecology. 107: 321-8. PMID 16449119 DOI: 10.1097/01.AOG.0000196500.50044.ce |
0.38 |
|
| 2006 |
Kulasingam SL, Kim JJ, Lawrence WF, Mandelblatt JS, Myers ER, Schiffman M, Solomon D, Goldie SJ. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute. 98: 92-100. PMID 16418511 DOI: 10.1093/Jnci/Djj009 |
0.47 |
|
| 2005 |
Havrilesky LJ, Kulasingam SL, Matchar DB, Myers ER. FDG-PET for management of cervical and ovarian cancer Gynecologic Oncology. 97: 183-191. PMID 15790456 DOI: 10.1016/J.Ygyno.2004.12.007 |
0.33 |
|
| 2004 |
Harris TG, Kulasingam SL, Kiviat NB, Mao C, Agoff SN, Feng Q, Koutsky LA. Cigarette smoking, oncogenic human papillomavirus, Ki-67 antigen, and cervical intraepithelial neoplasia. American Journal of Epidemiology. 159: 834-42. PMID 15105176 DOI: 10.1093/Aje/Kwh115 |
0.432 |
|
| 2004 |
Sawaya GF, McConnell KJ, Kulasingam SL, Lawson HW, Kerlikowske K, Melnikow J, Lee NC, Gildengorin G, Myers ER, Washington AE, Franco EL, Duarte-Franco EF. Screening every three years, instead of annually, would result in a small increase in risk of cervical cancer Evidence-Based Obstetrics and Gynecology. 6: 204-205. DOI: 10.1016/J.Ebobgyn.2004.09.009 |
0.453 |
|
| 2003 |
Sawaya GF, McConnell KJ, Kulasingam SL, Lawson HW, Kerlikowske K, Melnikow J, Lee NC, Gildengorin G, Myers ER, Washington AE. Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. The New England Journal of Medicine. 349: 1501-9. PMID 14561792 DOI: 10.1056/NEJMOA035419 |
0.505 |
|
| 2003 |
Kulasingam SL, Myers ER. Potential Health and Economic Impact of Adding a Human Papillomavirus Vaccine to Screening Programs Journal of the American Medical Association. 290: 781-789. PMID 12915431 DOI: 10.1001/Jama.290.6.781 |
0.483 |
|
| 2002 |
Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, Koutsky LA. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. Jama. 288: 1749-57. PMID 12365959 DOI: 10.1001/Jama.288.14.1749 |
0.411 |
|
| 2002 |
Baer A, Kiviat NB, Kulasingam S, Mao C, Kuypers J, Koutsky LA. Liquid-based Papanicolaou smears without a transformation zone component: should clinicians worry? Obstetrics and Gynecology. 99: 1053-9. PMID 12052599 DOI: 10.1016/S0029-7844(02)01998-1 |
0.369 |
|
| 2001 |
Kulasingam SL, Koutsky LA. Will New Human Papillomavirus Diagnostics Improve Cervical Cancer Control Efforts? Current Infectious Disease Reports. 3: 169-182. PMID 11286660 DOI: 10.1007/S11908-996-0054-0 |
0.416 |
|
| Show low-probability matches. |